Concepedia

C. Osborne

CO

Statistics

Publications

4

Citations

195

H-Index

4

Active since

2009

Affiliations

Texas Oncology(Current)

C. Osborne is an author at Texas Oncology specializing in cancer cell biology, breast cancer, and tumor biology.

Top concepts

Publications per year

2009–2019

4

Publications

4

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, C. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 94 citations

, , +11

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, C. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 44 citations

, , +11

Final Results of a Randomized Phase II Study Demonstrating Efficacy and Safety of BSI-201, a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor, in Combination with Gemcitabine/Carboplatin (G/C) in Metastatic Triple Negative Breast Cancer (TNBC).

Joyce O’Shaughnessy, Joyce O’Shaughnessy, Joyce O’Shaughnessy et al. · Cancer Research · 2009 · 41 citations

, , +12

Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones

Ben Yi Tew, Christophe Legendre, Mark A. Schroeder et al. · Neuro-Oncology · 2019 · 16 citations · Full text

Rows per page

1–4 of 4